Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry
Frank Hoentjen(Radboud University Nijmegen), Naomi T. Jessurun(Netherlands Pharmacovigilance Centre Lareb), Jette A. van Lint(Netherlands Pharmacovigilance Centre Lareb), Eline L. Giraud(Radboud University Nijmegen), Eugène van Puijenbroek(University of Groningen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Rachel West(Sint Franciscus Gasthuis), Jeroen M. Jansen(OLVG), Pepijn W. A. Thomas(Radboud University Nijmegen), Maurice G. Rüssel(Medisch Spectrum Twente)
Cited by 20
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
|The Lancet Neurology|2018|537
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis
|New England Journal of Medicine|2021|269
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252